Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy

Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy

The discovery of biomarkers for malignant tumors is driving the development of new radiopharmaceuticals in nuclear medicine. The development and optimization of novel radiopharmaceuticals to occupy an increasingly important role in tumor diagnosis and treatment. In recent years, fibroblast activatio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yihui Luo, Haitian Fu, Chunjing Yu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Pharmacology
Subjects:	fibroblast activation protein FAP fibroblast activation protein inhibitor FAPI targeted radioligand therapy radiopharmaceutical
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1593380/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Circulating soluble fibroblast activation protein (FAP) in patients with intra-thoracic cancer undergoing chest radiation
by: Tim Lange, et al.
Published: (2025-07-01)

Targeting fibroblast activation protein in rheumatoid arthritis: from molecular imaging to precision therapeutics
by: Yupeng Huang, et al.
Published: (2025-06-01)

Structure Optimization and Their Biodistribution in Tumor-bearing Mice on FAP and αⅤβ3 Dual Targeting Molecular Probes
by: WU Xiaoming1, 2, TIAN Guoxin3, WEN Xuejun2, 4, HE Tian1, 2, MA Fuqiu1, 3, XUE Yun1, 3
Published: (2025-04-01)

Fibroblast activation protein and the tumour microenvironment: challenges and therapeutic opportunities
by: Hsing Hwa Lee, et al.
Published: (2025-07-01)

Enhanced contrast in FAP-targeting PET imaging with 61Cu-labeled FAP inhibitors: development and preclinical evaluation of novel [61Cu]Cu-Kalios PET radioligands
by: Jacopo Millul, et al.
Published: (2025-08-01)

A fibroblast activation protein targeted optical tracer for identifying primary and metastatic sarcoma during resection
by: Feredun Azari, et al.
Published: (2025-07-01)

FAPi PET/CT Imaging to Identify Fibrosis in Immune-Mediated Inflammatory Diseases
by: Dalia A. Lartey, et al.
Published: (2025-03-01)

Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents
by: Juliette Fouillet, et al.
Published: (2024-11-01)

In vitro and ex vivo evaluation of preclinical models for FAP-targeted theranostics: differences and relevance for radiotracer evaluation
by: Circe D. van der Heide, et al.
Published: (2024-12-01)

Evaluation of myocardial fibrosis and wall motion abnormality with 68Ga-FAPI PET/MR in coronary heart disease
by: Rui Luo, et al.
Published: (2025-07-01)

Comparison of [18F]AlF-NOTA-FAPI-04 PET/CT and [18F]FDG PET/CT for diagnosing lymph node metastasis in malignant tumors
by: Wanjing Zhou, et al.
Published: (2025-07-01)

Characteristics of 18F-FAPI-04 PET/CT in patients with peritoneal metastasis and to predict treatment efficacy, a head-to-head comparison with 18F-FDG PET/CT
by: Yafei Zhang, et al.
Published: (2025-06-01)

Advances in novel imaging agents targeting fibroblast activation proteins
by: WANG Ning, SHI Yizhen
Published: (2025-05-01)

Molecular Imaging of Fibroblast Activation Protein in Response to Cardiac Injury Using [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>.SA.FAPi
by: Victoria Weissenböck, et al.
Published: (2025-04-01)

Preclinical evaluation of [68Ga]Ga-AAZTA-FAPI-46: a novel PET tracer for targeting fibroblast activation protein (FAP)
by: Rebecca Rizzo, et al.
Published: (2025-08-01)

The Role of Activated Stromal Cells in Fibrotic Foci Formation and Reversion
by: Nataliya Andreevna Basalova, et al.
Published: (2024-12-01)

Aged‐Related Fibroblast Activation Protein Expression in Skeletal Muscles Evaluated by PET Imaging
by: Minseok Suh, et al.
Published: (2025-02-01)

18F‐FAPI versus 18F‐FDG PET/CT in the Diagnosis of Relapsing Polychondritis
by: Xiaotong Guo, et al.
Published: (2024-12-01)

Gallium-Labeled PET Radiopharmaceuticals in Cardiovascular Disease
by: Matthieu Bailly, et al.
Published: (2025-03-01)

Protein-based Radiopharmaceuticals that target fibroblast activation protein alpha: a review of current progress
by: Abdelrahman Homedan, et al.
Published: (2025-06-01)

Association of α-SMA/FAP-positive cancer-associated fibroblasts with clinicopathological features and prognosis in extrahepatic cholangiocarcinoma
by: Xiaojun Sui, et al.
Published: (2025-07-01)

Spatial expression of fibroblast activation protein-α in clear cell renal cell carcinomas revealed by multiplex immunoprofiling analysis of the tumor microenvironment
by: Gorka Larrinaga, et al.
Published: (2025-01-01)

Locoregional radionuclide therapy of glioblastoma with [211At]At-PDA-FAPI
by: Huan Ma, et al.
Published: (2025-05-01)

Immunohistochemical Localization of Fibroblast Activation Protein in Coronary Arteries with Different Forms of Atherosclerosis
by: Adam Mohmand-Borkowski, et al.
Published: (2024-10-01)

The Role of Fibroblast Growth Factor Receptors Inhibitors in Bladder Cancer
by: Ho Kyung Seo, et al.
Published: (2024-07-01)

Research progress on positron emission tomography using radionuclide-labeled fibroblast activation protein inhibitor in diagnosis of cardiac diseases
by: JIA Yingqi, ZHANG Min, LI Biao
Published: (2025-04-01)

Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients
by: Richell Booijink, et al.
Published: (2025-07-01)

Fibroblast Activation Protein Compared with Other Markers of Activated Smooth Muscle Cells, Extracellular Matrix Turnover and Inflammation in a Mouse Model of Atherosclerosis
by: Adam Mohmand-Borkowski, et al.
Published: (2025-04-01)

Strategies for specific multimodal imaging of cancer-associated fibroblasts and applications in theranostics of cancer
by: Li Wen, et al.
Published: (2025-02-01)

PROTEIN SPECTRUM PRODUCED BY THE DERMAL FIBROBLASTS IN CHILDREN WITH CROHN’S DISEASE
by: V. S. Kropotov, et al.
Published: (2013-12-01)

Intercellular communication between FAP+ fibroblasts and SPP1+ macrophages in prostate cancer via multi-omics
by: Tingting Wu, et al.
Published: (2025-05-01)

Revolutionizing cancer diagnosis and dose biodistribution: a meta-analysis of [68ga] FAPI- 46 vs. [18f] FDG imaging
by: Samaneh Abbasi, et al.
Published: (2025-05-01)

Exploring Morphology of Thermoplasmonic Nanoparticles to Synergize Immunotherapeutic Fibroblast Activation Protein‐Positive Cell Sensitization and Photothermal Therapy
by: Ahmed Alsadig, et al.
Published: (2025-08-01)

The Development of Al<sup>18</sup>F-NOTA-FAP-2286 as an FAP-Targeted PET Tracer and the Translational Application in the Diagnosis of Acquired Drug Resistance in Progressive Prostate Cancer
by: Xia Du, et al.
Published: (2025-04-01)

Fibroblast Activation Protein Acts as a Biomarker for Monitoring ECM Remodeling During Aortic Aneurysm via 68Ga‐FAPI‐04 PET Imaging
by: Chengkai Hu, et al.
Published: (2025-04-01)

Immune modulation following α and β− radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model
by: Hannelore Ceuppens, et al.
Published: (2025-12-01)

Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics
by: William Serumula, et al.
Published: (2025-04-01)

Preclinical Study of a Dual-Target Molecular Probe Labeled with <sup>68</sup>Ga Targeting SSTR2 and FAP
by: Huanhuan Liu, et al.
Published: (2024-12-01)

Bilayer 3D co‐culture platform inducing the differentiation of normal fibroblasts into cancer‐associated fibroblast like cells: New in vitro source to obtain cancer‐associated fibroblasts
by: Yeon Ju Kim, et al.
Published: (2025-01-01)

Design, Synthesis, and Biological Evaluation of a Novel [<sup>18</sup>F]AlF-H<sub>3</sub>RESCA-FAPI Radiotracer Targeting Fibroblast Activation Protein
by: Qingyu Zhang, et al.
Published: (2025-02-01)